Brian L. Bray

1.5k total citations
22 papers, 1.1k citations indexed

About

Brian L. Bray is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Brian L. Bray has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 7 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in Brian L. Bray's work include HIV/AIDS drug development and treatment (5 papers), Chemical Synthesis and Analysis (4 papers) and HIV Research and Treatment (4 papers). Brian L. Bray is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), Chemical Synthesis and Analysis (4 papers) and HIV Research and Treatment (4 papers). Brian L. Bray collaborates with scholars based in United States, Poland and South Korea. Brian L. Bray's co-authors include Joseph M. Muchowski, Stanley Raucher, Dean R. Artis, Thomas T. Tidwell, Reto Naef, D. R. SOLAS, Ross F. Lawrence, Eric W. Schmidt, George R. Dubay and Joseph O. Falkinham and has published in prestigious journals such as Journal of the American Chemical Society, Nature Reviews Drug Discovery and The Journal of Organic Chemistry.

In The Last Decade

Brian L. Bray

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian L. Bray United States 13 596 591 112 100 74 22 1.1k
Bridget L. Stocker New Zealand 24 968 1.6× 937 1.6× 92 0.8× 90 0.9× 78 1.1× 94 1.8k
Jean‐Christophe Cintrat France 27 784 1.3× 784 1.3× 34 0.3× 76 0.8× 38 0.5× 88 1.8k
Siegfried S. F. Leung United States 14 513 0.9× 921 1.6× 201 1.8× 66 0.7× 119 1.6× 14 1.4k
Brigitte Jamart‐Grégoire France 22 806 1.4× 670 1.1× 81 0.7× 167 1.7× 39 0.5× 87 1.4k
Ester Muraglia Italy 18 483 0.8× 709 1.2× 73 0.7× 44 0.4× 21 0.3× 40 1.4k
Todd A. Houston Australia 19 973 1.6× 910 1.5× 26 0.2× 123 1.2× 125 1.7× 64 1.5k
Pál Herczegh Hungary 22 1.1k 1.9× 719 1.2× 93 0.8× 63 0.6× 182 2.5× 135 1.6k
Jérôme Désiré France 20 729 1.2× 727 1.2× 58 0.5× 30 0.3× 39 0.5× 55 1.1k
Lei Qiao China 18 688 1.2× 614 1.0× 28 0.3× 113 1.1× 39 0.5× 48 1.2k
Ferenc Sztaricskai Hungary 20 726 1.2× 532 0.9× 53 0.5× 22 0.2× 212 2.9× 102 1.2k

Countries citing papers authored by Brian L. Bray

Since Specialization
Citations

This map shows the geographic impact of Brian L. Bray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian L. Bray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian L. Bray more than expected).

Fields of papers citing papers by Brian L. Bray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian L. Bray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian L. Bray. The network helps show where Brian L. Bray may publish in the future.

Co-authorship network of co-authors of Brian L. Bray

This figure shows the co-authorship network connecting the top 25 collaborators of Brian L. Bray. A scholar is included among the top collaborators of Brian L. Bray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian L. Bray. Brian L. Bray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bray, Brian L., et al.. (2022). Abstract #1165627: Risperidone induced hyperprolactinemia levels-never seen before. Endocrine Practice. 28(5). S105–S105.
2.
Lim, Kyoung Soo, Stephen E. Schneider, Brian L. Bray, et al.. (2014). Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects. Drug Design Development and Therapy. 8. 1613–1613. 8 indexed citations
3.
Lin, Zhenjian, Joseph O. Falkinham, Peter W. Jeffs, et al.. (2012). Burkholdines from Burkholderia ambifaria: Antifungal Agents and Possible Virulence Factors. Journal of Natural Products. 75(9). 1518–1523. 51 indexed citations
4.
Schneider, Stephen E., Nicolai A. Tvermoes, John J. Dwyer, et al.. (2010). Convergent synthesis of a helical, prehairpin HR1 trimer from HIV gp41. Journal of Peptide Science. 16(9). 465–472. 1 indexed citations
5.
Jeffs, Peter W., Brian L. Bray, George R. Dubay, et al.. (2010). Burkholdines 1097 and 1229, Potent Antifungal Peptides from Burkholderia ambifaria 2.2N. Organic Letters. 12(4). 664–666. 54 indexed citations
6.
Schneider, Stephen E., et al.. (2007). Process Development of TRI-999, a Fatty-Acid-Modified HIV Fusion Inhibitory Peptide. Organic Process Research & Development. 12(1). 101–110. 12 indexed citations
7.
Payne, R. W., Rajiv Nayar, John Moschera, et al.. (2006). Second virial coefficient determination of a therapeutic peptide by self‐interaction chromatography. Biopolymers. 84(5). 527–533. 21 indexed citations
8.
Schneider, Stephen E., et al.. (2005). Development of HIV fusion inhibitors. Journal of Peptide Science. 11(11). 744–753. 32 indexed citations
9.
Bray, Brian L.. (2003). Large-scale manufacture of peptide therapeutics by chemical synthesis. Nature Reviews Drug Discovery. 2(7). 587–593. 475 indexed citations
10.
Bray, Brian L., et al.. (1995). Improved procedures for the preparation of (+) - (1R, 2S, 4R)-4-amino-2-hydroxy-1-hydroxymethyl cyclopentane. Tetrahedron Letters. 36(25). 4483–4486. 18 indexed citations
11.
12.
GUZMAN, A., Brian L. Bray, Robert Greenhouse, et al.. (1994). Oxidative radical cyclization to pyrroles under reducing conditions. Reductive desulfonylation of α-sulfonylpyrroles with tri-n-butyltin hydride. Canadian Journal of Chemistry. 72(1). 15–22. 65 indexed citations
13.
Bray, Brian L., Reto Naef, D. R. SOLAS, et al.. (1990). N-(Triisopropylsilyl)pyrrole. A progenitor "par excellence" of 3-substituted pyrroles. The Journal of Organic Chemistry. 55(26). 6317–6328. 201 indexed citations
14.
Bray, Brian L. & Joseph M. Muchowski. (1989). ChemInform Abstract: Synthesis of Acylpyrroles via α‐(Dimethylamino)‐α‐pyrrolylacetonitriles.. ChemInform. 20(25). 1 indexed citations
15.
Bray, Brian L. & Joseph M. Muchowski. (1988). Synthesis of acylpyrroles via .alpha.-(dimethylamino)-.alpha.-pyrrolylacetonitriles. The Journal of Organic Chemistry. 53(26). 6115–6118. 15 indexed citations
16.
17.
Raucher, Stanley & Brian L. Bray. (1987). A convenient procedure for the preparation of ethoxyacetylene and ethoxyethynyl carbinols. The Journal of Organic Chemistry. 52(11). 2332–2333. 21 indexed citations
18.
Raucher, Stanley, Brian L. Bray, & Ross F. Lawrence. (1987). Synthesis of (.+-.)-catharanthine, (+)-anhydrovinblastine, and (-)-anhydrovincovaline. Journal of the American Chemical Society. 109(2). 442–446. 57 indexed citations
19.
Raucher, Stanley & Brian L. Bray. (1985). Total synthesis of (.+-.)-catharanthine. The Journal of Organic Chemistry. 50(17). 3236–3237. 32 indexed citations
20.
Fraga, Serafín, K. M. S. Saxena, Jacek Karwowski, & Brian L. Bray. (1975). Atomic Ionization Potentials Derived from Theoretical Calculations. Canadian Journal of Physics. 53(21). 2415–2420. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bridget L. Stocker Breakdown of academic impact, for papers by Jean‐Christophe Cintrat Breakdown of academic impact, for papers by Siegfried S. F. Leung Breakdown of academic impact, for papers by Brigitte Jamart‐Grégoire Breakdown of academic impact, for papers by Ester Muraglia Breakdown of academic impact, for papers by Todd A. Houston Breakdown of academic impact, for papers by Pál Herczegh Breakdown of academic impact, for papers by Jérôme Désiré Breakdown of academic impact, for papers by Lei Qiao Breakdown of academic impact, for papers by Ferenc Sztaricskai
Rankless by CCL
2026